8 completed, 2 unknown, 1 terminated. 4 Not applicable, 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 3, Terminated 1 |
| Phase 4 | 3 | Completed 3 |
Follow Biosensing Techniques: new trials by email Literature Review of Biosensing Techniques trials Research Report on Biosensing Techniques
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemical Analysis of Limb Microfluidics Microdialysis catheter + biosensor - Limb Ischemia, Compartment Syndrome of Leg | Unknown | Imperial College London | 12 | 2023-02-01 | 2023-09-26 | |
| Wearable Devices to Monitor Seizures in Autoimmune Epilepsy Biosensor - Autoimmune Epilepsy, Healthy | Not applicable | Completed | Mayo Clinic | 33 | 2022-10-27 | 2024-11-26 |
| Validation of Ballistocardiographic Biosensors and Other Hemodynamic Measures for Healthy Subjects Biosensors - Hemodynamics, Biosensors | Completed | Oslo University Hospital | 20 | 2020-09-28 | 2020-10-14 | |
| Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation Biosensors - COVID 19 | Not applicable | Completed | Lars Wik | 138 | 2020-04-22 | 2022-09-21 |
| Digitally-Captured Step Counts for Evaluating Performance Status in Advanced Cancer Patients Wearable activity monitor - Cancer, Cancer, Metastatic | Unknown | Cedars-Sinai Medical Center | 80 | 2018-12-05 | 2024-08-27 | |
| Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With Cancer Fitbit Charge HR® - Neoplasms | Completed | Cedars-Sinai Medical Center | 37 | 2016-01-24 | 2017-09-25 | |
| Elderly Chronic Diseases Online Biometric Analysis Home Living Technology Biosensors, Home automation - The Elderly | Not applicable | Completed | University Hospital, Limoges | 536 | 2014-08-27 | 2026-03-27 |
| Comparison of Biomatrix and Orsiro Drug Eluting Stent Orsiro drug eluting stent, Biomatrix drug eluting stent - Coronary Artery Disease, Myocardial Ischemia | Phase 4 | Completed | Seoul National University Bundang Hospital | 2341 | 2014-07-01 | 2019-09-25 |
| BES, EES, and ZES-R in Real World Practice Biolimus-eluting stent, Everolimus-eluting stent, Zotarolimus-eluting stent - Coronary Artery Disease | Not applicable | Terminated | Yonsei University | 1960 | 2013-01-16 | 2019-07-09 |
| DES Versus BiOSS LIM - POLBOS II Study Coronary angioplasty with stent implantation, Dual antipletlet therapy (DAPT) - Coronary Artery Disease | Phase 4 | Completed | Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland | 202 | 2012-11-01 | 2015-07-30 |
| POLish Bifurcation Optimal Stenting Study Coronary angioplasty with stent implantation - Coronary Artery Disease | Phase 4 | Completed | Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland | 243 | 2010-10-01 | 2014-07-17 |
Coronary Artery Disease (4) · Neoplasms (2) · COVID-19 (1) · Compartment Syndromes (1) · Myocardial Ischemia (1) · Neoplasm Metastasis (1)
Cedars-Sinai Medical Center (2) · Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland (2) · Imperial College London (1) · Lars Wik (1) · Mayo Clinic (1) · Oslo University Hospital (1) · Seoul National University Bundang Hospital (1) · University Hospital, Limoges (1) · Yonsei University (1)
United States (3) · Norway (2) · Poland (2) · South Korea (2) · France (1) · United Kingdom (1)
Robert J Gil, MD, PhD (2) · Arvind Shinde, MD (1) · Benjamin Brinkmann, PhD (1) · Gillian Gresham, PhD (1) · In-Ho Chae, MD (1) · Junghan Yoon, M.D., Ph.D. (1) · Lars Wik, MD (1) · Lars Wik, MD, PhD (1)
PMID 33782985, PMID 23895804, PMID 25793605, PMID 29879021, PMID 32160779, PMID 36475473, PMID 37221865, PMID 40104139